ScholarWorks@Hanyang University: Kang, Ju Seop

Detailed Information

Kang, Ju Seop (강주섭)

COLLEGE OF MEDICINE (DEPARTMENT OF PHARMACOLOGY)

Research Area: 임상약리학, 신약개발

Tel 02-2220-0652
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

pharmacokinetics:13||LCMS/MS:10||Pharmacokinetics:10||Bioequivalence:5||bioequivalence test:4||bioequivalence study:4||Azelastine:2||bioequivalence:2||Korean red ginseng:2||Stability:2||ACF:2||βglucan:2||Colon carcinogenesis:2||oxidative stress:2||Rats:2||liver cirrhosis:2||Intravenous Elastomeric Infusion Device (Accufuser®):2||Bioequivalence study:2||Biomedical field:1||Breast neoplasms:1||CAH:1||CAS 61869087:1||CAS 80832236:1||COVID19:1||Cephalosporin Antibiotic:1||Cephradine:1||ChildPugh class:1||Chimeric antigen receptor T cell:1||Chlorella vulgaris:1||Cirrhosis:1||Cudrania tricuspidata Stem:1||Curcumin:1||DLco:1||DLco/VA:1||DSF:1||Dermatophagoides farina:1||Dextran sulfate sodium:1||Disease activity index (DAI):1||Doxylamine intoxication:1||Drug delivery system:1||Drug monitoring:1||Enalapril:1||Enzymatic Porcine Placental Extract:1||Ethanol:1||Etodolac:1||Exocytosis:1||Exosome:1||GC/MS:1||H/L ratio:1||HPLC method:1||HPLCFLD method:1||HPLCUV Method:1||HPLC/MS/MS:1||Hepatotoxicity:1||Homeostasis:1||Hyperphenylalaninemia:1||Immunoglobulin E (IgE):1||Infusion device:1||Inhibitor:1||Internal standard:1||Isradipine:1||Korean Volunteers:1||Korean population:1||Korean soy sauce:1||LCESI/MS/MS:1||LCMS/MS method:1||Metaanalysis:1||Metabolic activity:1||Mice liver:1||Nmonodesmethyl trimebutine:1||NC/Nga Mouse:1||NSAIDs:1||Nafcillin Sodium:1||Neuron:1||Neurophil:1||Nitric oxide:1||Osteoclast differentiation:1||Otsuka LongEvans Tokushima Fatty diabetic rat:1||Paroxetine, bioequivalence study, liquid chromatography/tandem mass spectrometry, pharmacokinetics:1||Penicillin G potassium:1||Plasma concentration:1||Portosystemic shunt (H/L ratio):1||Prediction model for dose of ingestion:1||Propranolol:1||Proteolysis:1||Puffed red ginseng:1||Pulmonary diffusion capacity:1||RAW264:1||RON protein:1||SLUG:1||SOT:1||STZinduced diabetic rat:1||Selaginella tamariscina:1||Solid organ transplantation:1||Solution Stability:1||Tetrahydrobiopterin:1||Theragnostics:1||Therapeutic:1||Therapeutic drug monitoring (TDM):1||Ubiquitin proteasome system:1||Ulcerative colitis (UC):1||Urinary bladder neoplasms:1||Venlafaxine:1||aceclofenac:1||alcoholic fatty liver:1||alcoholic hepatotoxicity:1||alendronate sodium:1||alkaliphilic Bacillus sp K1:1||anterior approach:1||antiinflammatories, nonsteroidal:1||antidepressants:1||antioxidant enzyme:1||area under the receiver operating characteristics curve:1||bacterial vaginosis:1||basal type breast cancer cells:1||bloequivalence test:1||burst fracture:1||cancer metastasis:1||carbenoxolone:1||cellulase/cellulosebinding factor:1||chemical identification:1||chronic liver disease:1||ciprofloxacin:1||cyclooxygenase2:1||epithelialmesenchymal transition:1||ethyl carbamate:1||extracellular:1||fibrosis:1||gabapentin:1||guamerin:1||hepatic ADH:1||hepatic ALDH:1||hepatic injury:1||hepatic ischemiareperfusion:1||imidapril:1||insulin resistance:1||interleukin6:1||internal standard:1||intestinal epithelial cells NFkappa B:1||joint pain:1||korean volunteers:1||lead toxicity:1||leukocyte elastase inhibitor:1||levosulpiride:1||lignocellulosic substances:1||limaprost:1||liquid chromatography:1||liquid chromatographytandem mass spectrometry with electrospray ionization (LCESI/MS/MS):1||liquidliquid extraction:1||liver fibrosis.:1||low back pain:1||loxoprofen, bioequivalence, pharmacokinetics:1||lumbar spinal canal stenosis (LSCS):1||mass spectrometry:1||metformin:1||microbiological identification:1||microorganism:1||mosapride:1||multienzyme complex:1||musculoskeletal pain:1||myocardial injury:1||omeprazole:1||pPEM (porcine placenta extract mixture):1||pancreatitis:1||pelletbound and intracellular fractions:1||per rectum ²⁰¹Tl scintigraphy:1||phloroglucinol:1||plasmaactivated water:1||plasmaactivated water (PAW):1||portal venous flow:1||propranolol:1||prostaglandin E2:1||prostaglandin E1 analogue:1||receptor activator for nuclear factorB ligand:1||residual antibiotics:1||sleep duration:1||the Koreans:1||thioacetamide:1||thromboangiitis obliterans (TAO):1||tiropramide:1||titanium mesh cage:1||topiramate:1||tricortical autogenous iliac bone grafting:1||trimebutine maleate:1||tumor necrosis factoralpha:1||type 2 diabetes:1||underwater plasma discharge:1||vaginal cleaning:1||vaginal cleansing effect:1||vaginitis(suspected) patients:1||xylanase/xylanbinding factor:1||xylanolytic enzymes:1||11 betahydroxysteroid dehydrogenase type 1:1||βglucuronidas:1||7 cells:1||Accufuser®:1||Adenocarcinoma of lung:1||Alcohol Dehydrogenase:1||Alcohol Metabolism:1||Aldehyde Dehydrogenase:1||Ampicillin Sodium:1||Analytical method:1||Angiotensinconverting enzyme (ACE) inhibitor:1||Antidiabetic effect:1||Antiepileptic drugs (AEDs):1||Aquaporin:1||Aspirin stability curcumin admixture HPLC:1||Atopic Dermatitis:1||Bacteroides fragilis enterotoxin:1||Biological fluids:1||Biomarker:1||

STATISTICS: Total View :6,146,718; Today View :8,010

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE